{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:41:37Z","timestamp":1791132097115,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ejpb.2013.03.020","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T11:48:24Z","timestamp":1365076104000},"page":"604-613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"PA","title":["Steroid\/mucokinetic hybrid nanoporous microparticles for pulmonary drug delivery"],"prefix":"10.1016","volume":"85","author":[{"given":"Frederic","family":"Tewes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof J.","family":"Paluch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Tajber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devesh","family":"Kalantri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Ehrhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2013.03.020_b0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jcf.2003.12.005","article-title":"Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study","volume":"3","author":"Westerman","year":"2004","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1016\/j.ejpb.2013.03.020_b0010","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0140-6736(10)60926-9","article-title":"Aerosol drug delivery: developments in device design and clinical use","volume":"377","author":"Dolovich","year":"2011","journal-title":"The Lancet"},{"key":"10.1016\/j.ejpb.2013.03.020_b0015","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1378\/chest.102.5.1544","article-title":"Formoterol suspension aerosol. Comparison with formoterol solution aerosol for 12weeks in asthmatic patients","volume":"102","author":"Maesen","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.ejpb.2013.03.020_b0020","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1128\/AAC.00329-09","article-title":"Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose-dependent interactions between anidulafungin and voriconazole by bliss independence drug interaction analysis","volume":"53","author":"Petraitis","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.ejpb.2013.03.020_b0025","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11095-009-9991-2","article-title":"Inhalable antibiotic delivery using a dry powder co-delivering recombinant deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosis","volume":"27","author":"Yang","year":"2010","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.ejpb.2013.03.020_b0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejps.2010.02.004","article-title":"Can low-dose combination products for inhalation be formulated in single crystalline particles?","volume":"40","author":"Kumon","year":"2010","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.ejpb.2013.03.020_b0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11095-006-9130-2","article-title":"In vitro investigation of drug particulates interactions and aerosol performance of pressurised metered dose inhalers","volume":"24","author":"Traini","year":"2007","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.ejpb.2013.03.020_b0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jcf.2006.03.007","article-title":"Inhalation solutions \u2013 which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers","volume":"5","author":"Kamin","year":"2006","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1016\/j.ejpb.2013.03.020_b0045","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1378\/chest.124.1.360","article-title":"Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers","volume":"124","author":"Newhouse","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.ejpb.2013.03.020_b0050","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.ejpb.2008.04.020","article-title":"Characterisation of excipient-free nanoporous microparticles (NPMPs) of bendroflumethiazide","volume":"69","author":"Healy","year":"2008","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.ejpb.2013.03.020_b0055","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ejps.2009.05.007","article-title":"Excipient-free nanoporous microparticles of budesonide for pulmonary delivery","volume":"37","author":"Nolan","year":"2009","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.ejpb.2013.03.020_b0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijpharm.2010.11.040","article-title":"Particle engineering of materials for oral inhalation by dry powder inhalers. II \u2013 Sodium cromoglicate","volume":"405","author":"Nolan","year":"2011","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ejpb.2013.03.020_b0065","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00003088-200140060-00004","article-title":"Clinical pharmacokinetics of inhaled budesonide","volume":"40","author":"Donnelly","year":"2001","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.ejpb.2013.03.020_b0070","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1164\/rccm.200408-1041OC","article-title":"Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy","volume":"172","author":"Usmani","year":"2005","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.ejpb.2013.03.020_b0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.prrv.2011.05.009","article-title":"Inhaled corticosteroids should be the first line of treatment for children with asthma","volume":"12","author":"Brand","year":"2011","journal-title":"Paediatric Respiratory Reviews"},{"key":"10.1016\/j.ejpb.2013.03.020_b0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0002-9343(02)01143-9","article-title":"The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials","volume":"113","author":"Alsaeedi","year":"2002","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.ejpb.2013.03.020_b0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0954-6111(95)90249-X","article-title":"The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis","volume":"89","author":"Van Haren","year":"1995","journal-title":"Respiratory Medicine"},{"key":"10.1016\/j.ejpb.2013.03.020_b0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jcf.2005.05.010","article-title":"Anti-inflammatory therapy in cystic fibrosis","volume":"4","author":"Dinwiddie","year":"2005","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1016\/j.ejpb.2013.03.020_b0095","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0169-409X(01)00115-6","article-title":"Drug transfer through mucus","volume":"48","author":"Khanvilkar","year":"2001","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.ejpb.2013.03.020_b0100","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1021\/mp100242r","article-title":"Disruption of the mucus barrier by topically applied exogenous particles","volume":"7","author":"McGill","year":"2010","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.ejpb.2013.03.020_b0105","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1517\/17460441.2011.629646","article-title":"Ambroxol: a multifaceted molecule with additional therapeutic potentials in respiratory disorders of childhood","volume":"6","author":"Paleari","year":"2011","journal-title":"Expert Opinion on Drug Discovery"},{"key":"10.1016\/j.ejpb.2013.03.020_b0110","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.bbrc.2006.03.009","article-title":"Ambroxol-induced modification of ion transport in human airway Calu-3 epithelia","volume":"343","author":"Hasegawa","year":"2006","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.ejpb.2013.03.020_b0115","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/jps.21529","article-title":"Pulmonary selectivity and local pharmacokinetics of ambroxol hydrochloride dry powder inhalation in rat","volume":"98","author":"Ren","year":"2009","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.ejpb.2013.03.020_b0120","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejps.2010.07.001","article-title":"Development and characterisation of soluble polymeric particles for pulmonary peptide delivery","volume":"41","author":"Tewes","year":"2010","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.ejpb.2013.03.020_b0125","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1021\/mp200231c","article-title":"Evaluation of HP\u03b2CD-PEG microparticles for salmon calcitonin administration via pulmonary delivery","volume":"8","author":"Tewes","year":"2011","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.ejpb.2013.03.020_b0130","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/jps.10151","article-title":"Transport and local metabolism of budesonide and fluticasone propionate in a human bronchial epithelial cell line (Calu-3)","volume":"91","author":"Borchard","year":"2002","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.ejpb.2013.03.020_b0135","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejpb.2005.02.010","article-title":"Human respiratory epithelial cell culture for drug delivery applications","volume":"60","author":"Forbes","year":"2005","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.ejpb.2013.03.020_b0140","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1021\/mp1003674","article-title":"A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole\/polyvinylpyrrolidone and sulfadimidine\/polyvinylpyrrolidone","volume":"8","author":"Caron","year":"2011","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.ejpb.2013.03.020_b0145","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1080\/03639040802154913","article-title":"Influence of formulation and preparation process on ambroxol hydrochloride dry powder inhalation characteristics and aerosolization properties","volume":"34","author":"Ren","year":"2008","journal-title":"Drug Development and Industrial Pharmacy"},{"key":"10.1016\/j.ejpb.2013.03.020_b0150","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11095-006-9174-3","article-title":"Particle engineering for pulmonary drug delivery","volume":"24","author":"Chow","year":"2007","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.ejpb.2013.03.020_b0155","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/A:1014426530935","article-title":"Fundamental effects of particle morphology on lung delivery: predictions of Stokes\u2019 law and the particular relevance to dry powder inhaler formulation and development","volume":"19","author":"Crowder","year":"2002","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.ejpb.2013.03.020_b0160","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1126\/science.276.5320.1868","article-title":"Large porous particles for pulmonary drug delivery","volume":"276","author":"Edwards","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ejpb.2013.03.020_b0165","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.talanta.2003.08.027","article-title":"The thermodynamic dissociation constants of ambroxol, antazoline, naphazoline, oxymetazoline and ranitidine by the regression analysis of spectrophotometric data","volume":"62","author":"Meloun","year":"2004","journal-title":"Talanta"},{"key":"10.1016\/j.ejpb.2013.03.020_b0170","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1021\/ja01350a001","article-title":"Dielectric constants of some organic solvent\u2013water mixtures at various temperatures","volume":"54","author":"Akerlof","year":"1932","journal-title":"Journal of the American Chemical Society"},{"key":"10.1016\/j.ejpb.2013.03.020_b0175","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0378-5173(97)04907-7","article-title":"Potentiometric pKa determination of water-insoluble compounds: validation study in methanol\/water mixtures","volume":"151","author":"Tak\u00e1cs-Nov\u00e1k","year":"1997","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ejpb.2013.03.020_b0180","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1023\/B:JTAN.0000039001.05945.42","article-title":"Thermal and structural properties of ambroxol polymorphs","volume":"77","author":"Caira","year":"2004","journal-title":"Journal of Thermal Analysis and Calorimetry"},{"key":"10.1016\/j.ejpb.2013.03.020_b0185","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.powtec.2008.10.021","article-title":"The effect of processing parameters on particle size in ammonia-induced precipitation of zirconyl chloride under industrially relevant conditions","volume":"191","author":"Carter","year":"2009","journal-title":"Powder Technology"},{"key":"10.1016\/j.ejpb.2013.03.020_b0190","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrd2153","article-title":"Inhaling medicines: delivering drugs to the body through the lungs","volume":"6","author":"Patton","year":"2007","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.ejpb.2013.03.020_b0195","doi-asserted-by":"crossref","unstructured":"D.A. Edwards, C. Dunbar, Bioengineering of therapeutic aerosols, 2002, pp. 93\u2013107.","DOI":"10.1146\/annurev.bioeng.4.100101.132311"},{"key":"10.1016\/j.ejpb.2013.03.020_b0200","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.bbrc.2009.01.122","article-title":"Action of N-acylated ambroxol derivatives on secretion of chloride ions in human airway epithelia","volume":"380","author":"Yamada","year":"2009","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.ejpb.2013.03.020_b0205","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4149\/gpb_2009_03_309","article-title":"Transepithelial transport of ambroxol hydrochloride across human intestinal Caco-2 cell monolayers","volume":"28","author":"\u0160t\u011btinov\u00e1","year":"2009","journal-title":"General Physiology and Biophysics"},{"key":"10.1016\/j.ejpb.2013.03.020_b0210","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0928-0987(99)00007-X","article-title":"Mucus as a barrier to the permeability of hydrophilic and lipophilic compounds in the absence and presence of sodium taurocholate micellar systems using cell culture models","volume":"8","author":"Meaney","year":"1999","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.ejpb.2013.03.020_b0215","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s11095-006-0255-0","article-title":"Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier","volume":"23","author":"Grainger","year":"2006","journal-title":"Pharmaceutical Research"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641113001094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641113001094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T16:54:29Z","timestamp":1562864069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641113001094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0939641113001094"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2013.03.020","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Steroid\/mucokinetic hybrid nanoporous microparticles for pulmonary drug delivery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2013.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}